New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Adding immunotherapy after initial treatment can benefit metastatic lung cancer patients

Adding immunotherapy after initial treatment can benefit metastatic lung cancer patients

by Perelman School of Medicine at the University of PennsylvaniaTreating metastatic non-small cell lung cancer (NSCLC) patients with the immunotherapy drug pembrolizumab after they've complet
Oncology May 05,2024
Adding immunotherapy after initial treatment can benefit metastatic lung cancer patients

Adding immunotherapy after initial treatment can benefit metastatic lung cancer patients

by Perelman School of Medicine at the University of PennsylvaniaTreating metastatic non-small cell lung cancer (NSCLC) patients with the immunotherapy drug pembrolizumab after they've complet
Oncology May 05,2024
No clear link between local food and cancer risk in glassworks areas

No clear link between local food and cancer risk in glassworks areas

by Linköping UniversityCredit: CC0 Public DomainThere is no clear link between cancer incidence and locally produced food from an area with a history of glass manufacture with contaminated soil,
Oncology May 05,2024
No clear link between local food and cancer risk in glassworks areas

No clear link between local food and cancer risk in glassworks areas

by Linköping UniversityCredit: CC0 Public DomainThere is no clear link between cancer incidence and locally produced food from an area with a history of glass manufacture with contaminated soil,
Oncology May 05,2024
Genes responsible for sex-related differences in cancer aggressiveness found in vinegar flies

Genes responsible for sex-related differences in cancer aggressiveness found in vinegar flies

by Institute for Research in Biomedicine (IRB Barcelona)Differences between tumours in male and female vinegar flies. Credit: Cayetano González, IRB BarcelonaAn understanding of the molecular bas
Oncology May 05,2024
Genes responsible for sex-related differences in cancer aggressiveness found in vinegar flies

Genes responsible for sex-related differences in cancer aggressiveness found in vinegar flies

by Institute for Research in Biomedicine (IRB Barcelona)Differences between tumours in male and female vinegar flies. Credit: Cayetano González, IRB BarcelonaAn understanding of the molecular bas
Oncology May 05,2024
HPV DNA identified in oral cavity of 6.2 percent of teen girls

HPV DNA identified in oral cavity of 6.2 percent of teen girls

(HealthDay)—Human papillomavirus (HPV) DNA is detected in the oral cavities of about 6.2 percent of sexually active female adolescents, according to a study published online Oct. 25 inJAMA Netwo
Oncology May 05,2024
HPV DNA identified in oral cavity of 6.2 percent of teen girls

HPV DNA identified in oral cavity of 6.2 percent of teen girls

(HealthDay)—Human papillomavirus (HPV) DNA is detected in the oral cavities of about 6.2 percent of sexually active female adolescents, according to a study published online Oct. 25 inJAMA Netwo
Oncology May 05,2024
Vaccine to prevent a dangerous tropical disease receives approval

Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea
Public Health & Prevention May 05,2024
Vaccine to prevent a dangerous tropical disease receives approval

Vaccine to prevent a dangerous tropical disease receives approval

by Estonian Research CouncilWork in Tartu University's virology lab. Author Kaspar Koolmeister. Credit: Kaspar KoolmeisterThe chikungunya virus is widespread in tropical regions, where it is sprea
Public Health & Prevention May 05,2024
Clinicians, practices and patients all have a part to play in dealing with risks of remote GP consultations

Clinicians, practices and patients all have a part to play in dealing with risks of remote GP consultations

by University of OxfordCredit: Unsplash/CC0 Public DomainWhile most remote GP consultations are safe, the "Remote by Default" study finds that GP consultations conducted remotely carry
Oncology May 05,2024
Clinicians, practices and patients all have a part to play in dealing with risks of remote GP consultations

Clinicians, practices and patients all have a part to play in dealing with risks of remote GP consultations

by University of OxfordCredit: Unsplash/CC0 Public DomainWhile most remote GP consultations are safe, the "Remote by Default" study finds that GP consultations conducted remotely carry
Oncology May 05,2024
Number of cancer treatments provided decreased in first year of COVID-19

Number of cancer treatments provided decreased in first year of COVID-19

by Elana GotkineIn the first year of the pandemic, there was a significant decrease in the number of cancer treatments provided, resulting from a decrease in the number of cancer diagnoses, according
Oncology May 05,2024
Number of cancer treatments provided decreased in first year of COVID-19

Number of cancer treatments provided decreased in first year of COVID-19

by Elana GotkineIn the first year of the pandemic, there was a significant decrease in the number of cancer treatments provided, resulting from a decrease in the number of cancer diagnoses, according
Oncology May 05,2024
Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

by University of Massachusetts AmherstBacterial delivery of ovalbumin induces a specific CD8 T cell response. Credit:Frontiers in Immunology(2023). DOI: 10.3389/fimmu.2023.1228532A Un
Oncology May 05,2024
Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

by University of Massachusetts AmherstBacterial delivery of ovalbumin induces a specific CD8 T cell response. Credit:Frontiers in Immunology(2023). DOI: 10.3389/fimmu.2023.1228532A Un
Oncology May 05,2024
Herd protection against oral HPV infections seen among men

Herd protection against oral HPV infections seen among men

In unvaccinated men aged 18 to 59 years, the prevalence of vaccine-type oral human papillomavirus (HPV) decreased between 2009 to 2010 and 2015 to 2016, according to a research letter published in the
Oncology May 05,2024
Herd protection against oral HPV infections seen among men

Herd protection against oral HPV infections seen among men

In unvaccinated men aged 18 to 59 years, the prevalence of vaccine-type oral human papillomavirus (HPV) decreased between 2009 to 2010 and 2015 to 2016, according to a research letter published in the
Oncology May 05,2024
Exercise associated with benefit to patients with advanced colorectal cancer

Exercise associated with benefit to patients with advanced colorectal cancer

by Dana-Farber Cancer InstituteDr. Meyerhardt is the clinical director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute and the senior author of the study. Credit: Dana-Farbe
Oncology May 05,2024
Exercise associated with benefit to patients with advanced colorectal cancer

Exercise associated with benefit to patients with advanced colorectal cancer

by Dana-Farber Cancer InstituteDr. Meyerhardt is the clinical director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute and the senior author of the study. Credit: Dana-Farbe
Oncology May 05,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com